New Biosensors Use Saliva for At-Home Health Monitoring
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
Researchers developed a device that detects glucose and adenosine monophosphate (AMP) biomarkers in saliva with high sensitivity.
New research from NIH found that blood glucose levels obtained at childhood examinations predicted future diabetes-related complications.
A research team has identified a new non-invasive screening method for Type 2 diabetes (T2D) by harnessing urinary acetones.
A proteomics approach was used to identify a three-protein signature in the blood that can improve detection of a form of prediabetes.
Read MoreAlimentiv and Summit Clinical Research are collaborating to drive Non-Alcoholic Steatohepatitis drug development programs forward.
Read MoreChildren who were infected with COVID show a substantially higher risk of developing type 1 diabetes (T1D), according to a new study.
Read MoreNonalcoholic steatohepatitis, a type of fatty liver disease that might progress to cancer, is a prevalent health concern among the obese.
Read MoreResearchers at NuraLogix developed AI models that can predict a person’s risk of HbA1C levels and fasting blood glucose levels.
Read MoreThe earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma.
Read MoreIntuity Medical announced that the POGO Automatic Blood Glucose Monitoring System is available at U.S. pharmacies of Kroger Health.
Read MoreA new study estimates that the number of undiagnosed diabetes cases in the U.S. is significantly lower than current estimates suggest.
Read MoreThis liquid biopsy test uses two circulating proteins to accurately test for non-alcoholic steato-hepatitis (NASH) and liver fibrosis.
Read MoreIn a study led by MedUni Vienna, a new method has now been used to determine alcohol consumption in fatty liver disease.
Read MoreA specific subtype of macrophages in progressive NAFLD serve as useful biomarkers of liver disease progression.
Read MoreA new test could more accurately predict if individuals who undergo gastric bypass surgery will experience a remission of type 2 diabetes.
Read MoreAbbott is developing a new biowearable that will continuously monitor glucose and ketone levels in one sensor.
Read MoreBlood-based tests can be useful for initial diagnosis of liver disorders. Imaging methods are more accurate in assessing disorders severity.
Read MoreThe FDA cleared Abbott’s next-generation FreeStyle Libre 3 system for use by people four years and older living with diabetes.
Read More